培养细胞在烧伤治疗中的附加价值:一项系统综述
本系统综述遵循PRISMA指南检索三个数据库,纳入14项临床研究(8项随机对照试验、5项前瞻性队列试验、1项回顾性队列研究),评估培养细胞在烧伤治疗中的应用。多种组织工程皮肤替代物从培养表皮自体移植到接种培养细胞的真皮再生模板均显示有前景的结果,部分替代物的成活率与断层皮片移植相当且瘢痕质量改善。结论认为结果有前景,但仍缺乏培养皮肤替代物的标准化以及更大样本和合适对照的稳健临床试验。
要点
- 纳入14项临床研究,包括8项随机对照试验、5项前瞻性队列试验和1项回顾性队列研究。
- 多种组织工程皮肤替代物显示有前景的结果,部分替代物成活率与断层皮片移植相当且瘢痕质量改善。
- 仍缺乏培养皮肤替代物的标准化以及更大样本和合适对照的稳健临床试验。
核心结论
- 结果有前景,但仍缺乏培养皮肤替代物的标准化以及更大样本和合适对照的稳健临床试验。
研究设计与样本
- 遵循PRISMA指南,在PubMed、Embase、Cochrane Library三个数据库进行全面检索,仅纳入临床研究,由两名独立评审员筛选文章并进行质量评估。
- 检索获得167篇文章,其中14篇符合纳入标准,包括8项随机对照试验、5项前瞻性队列试验和1项回顾性队列研究。
主要发现
- 多种组织工程皮肤替代物,从培养表皮自体移植到接种培养细胞的真皮再生模板,均显示有前景的结果。
- 部分替代物表现出与断层皮片移植相当的成活率,且瘢痕质量改善。
临床怎么用
- 原文未据此给出推荐。
局限性
- 仍缺乏培养皮肤替代物的标准化以及更大样本和合适对照的稳健临床试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Advancements in resuscitative care and burn surgery have improved survival rates after extensive burn injuries, shifting focus to enhancing the quality of survival. Conventional treatment with split-thickness skin grafts (STSG) presents limitations such as donor-site morbidity, limited availability in extensive burn injuries, and hypertrophic scarring. Tissue engineering aims to address these drawbacks by developing optimal skin substitutes. This systematic review aims to provide an overview of the current applications of cultured cells in burn surgery, encompassing diverse approaches and addressing existing challenges to enhance burn wound management and improve patient outcomes. METHODS: Following PRISMA guidelines, a comprehensive search was performed across three databases (PubMed, Embase, Cochrane Library) for articles on cultured cell use in burn treatment. Only clinical studies were included. Articles were screened by two independent reviewers. Quality assessment was performed. RESULTS: The search yielded 167 articles, of which 14 met the eligibility criteria. The selection included 8 randomized controlled trials, 5 prospective cohort trials, and 1 retrospective cohort study. Various tissue-engineered skin substitutes, from cultured epidermal autografts to dermal regeneration templates seeded with cultured cells, showed promising outcomes. Several substitutes exhibited take rates comparable to STSG with improved scar quality. CONCLUSION: Results are promising, though standardization of cultured skin substitutes and robust clinical trials with larger populations and appropriate comparators are still lacking.
引用
- Simaey M, De Decker I, Vanlauwe F, et al. The added value of cultured cells in burn treatment: A systematic review. Burns. 2024. PMID: 39447287. doi:10.1016/j.burns.2024.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。